Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,674,173 papers from all fields of science
Search
Sign In
Create Free Account
MAGE-A3 peptide vaccine
Known as:
MAGE-A3
A peptide cancer vaccine comprised of a peptide derived from the human melanoma antigen A3 (MAGE-A3), with potential immunostimulating and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Antigen Sensitization
Narrower (1)
Astuprotimut-R
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
MAGE-A3 Lung Cancer Vaccine Provides No Benefit Over Placebo
D. Levitan
2014
Corpus ID: 146011977
The MAGRIT trial showed no benefit with the recMAGE-A3 + AS15 cancer immunotherapeutic compared with placebo in completely…
Expand
Review
2013
Review
2013
Immunotherapy for lung cancer : ongoing clinical trials REVIEW
S. Declerck
,
J. Vansteenkiste
2013
Corpus ID: 261026813
91 ISSN 1479-6694 10.2217/FON.13.166 © 2014 Future Medicine Ltd Future Oncol. (2014) 10(1), 91–105 ABSTRACT: Modulation of a…
Expand
2013
2013
Analysis of Spontaneous vs. Vaccine-induced Antibody Responses against Antigens MAGE-A3 and MAGE-C2 in Cancer Patients
Yanran Cao
2013
Corpus ID: 70469951
Article history: Received 21 December 2009 Received in revised form 9 March 2010 Accepted 11 March 2010 Available online 17 March…
Expand
2013
2013
Abstract LB-320: Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer.
A. Tessari
,
L. Pilla
,
+5 authors
S. Cresta
2013
Corpus ID: 72826954
Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Background: Melanoma studies have highlighted the…
Expand
2010
2010
Abstract 4796: Treatment with chromatin remodeling agents increases MAGE-A3 expression in pancreatic cancer and enhances antigen-specific recognition by T lymphocytes
Alexandria P. Cogdill
,
Andrea Boni
,
+7 authors
J. Wargo
2010
Corpus ID: 75261315
Pancreatic cancer is the fourth leading cause of cancer death in the United States and is frequently lethal despite aggressive…
Expand
2010
2010
Adjuvante systemische Therapie des Melanoms
Hauschild
Der Hautarzt
2010
Corpus ID: 28611672
Despite intensive clinical and research efforts during the last decades the prognosis for patients with stage IV melanoma still…
Expand
2009
2009
Antigen Expression in Multiple Myeloma Longitudinal Analysis and Prognostic Effect of Cancer-Testis
T. Luetkens
,
Y. Hildebrandt
,
+7 authors
Nicolaus Kro
2009
Corpus ID: 17068837
Purpose: Reliable data on the persistence of tumor expression of cancer-testis (CT) antigens over time and consequent analyses of…
Expand
2007
2007
MAGE-A3 vaccine
J. Vansteenkiste
2007
Corpus ID: 79434525
2006
2006
Detection of MAGE-A3 Antigen and HLA-class I Genes Distribution in Lung Cancer
Na Wang
,
Dong-Gang Zhuang
,
Yue Ba
,
Yiming Wu
2006
Corpus ID: 53700773
Aim. In order to speculate the ratio of lung cancer patients who can be treated with immunotherapy based on MAGE-A3 antigen, the…
Expand
2001
2001
Adjuvante systemische Therapie des Melanoms
K. Kähler
,
F. Egberts
,
A. Hauschild
,
P. Mohr
Der Onkologe
2001
Corpus ID: 25013810
ZusammenfassungTrotz aller klinisch-wissenschaftlichen Bemühungen in den letzten Jahrzehnten ist die Prognose von Patienten mit…
Expand